enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · IEX Real-Time Price · USD
9.00
0.00 (0.00%)
Jul 26, 2024, 4:30 PM EDT - Market closed
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $397.50 million as of July 26, 2024. Its market cap has increased by 133.82% in one year.
Market Cap
397.50M
Enterprise Value
157.29M
1-Year Change
133.82%
Ranking
Category
Stock Price
$9.00
Market Cap Chart
Since December 10, 2021, enGene Holdings's market cap has increased from $124.90M to $397.50M, an increase of 218.25%. That is a compound annual growth rate of 55.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 397.50M | 85.66% |
| Dec 29, 2023 | 214.10M | 31.11% |
| Dec 30, 2022 | 163.30M | 30.12% |
| Dec 31, 2021 | 125.50M | 0.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 416.07M |
| Lyell Immunopharma | 415.55M |
| Esperion Therapeutics | 414.12M |
| AxoGen | 407.76M |
| Sight Sciences | 399.54M |
| Revance Therapeutics | 392.72M |
| Alto Neuroscience | 389.55M |
| Lexeo Therapeutics | 388.43M |